Landmark Research Study is Launched to Assess Impact of Personal Genet...(x. Navigenics harnesses the powerof the...),Health

Researchers will use the genetic variations found in the study as a tool to continue to study genes linked to many diseases. The study affords researchers the opportunity to better understand ways to prevent, diagnose and treat disease.

"Personalized medicine stands to change the way people approach their health and wellness, as well as open up new genetic research opportunities," said Peter Neupert, corporate vice president, Health Solutions Group, Microsoft, Inc. "This collaboration is a significant step forward in empowering people to proactively address their specific individual health needs, as well as give clinical researchers access to a broader pool of genetic data to develop new disease treatments."

ABOUT SCRIPPS TRANSLATIONAL SCIENCE INSTITUTE

Founded in 2006, Scripps Translational Science Institute (STSI) is an initiative of Scripps Health, in collaboration with The Scripps Research Institute. STSI initiates research designed to help move basic research from the lab to the patient bedside, bridging the gap between basic science and clinical trials. Scripps Genomic Medicine is a program of STSI and involves genotyping tens of thousands of individuals to identify and define genes responsible for major diseases and the underpinnings of health. Scripps Health is a $2 billion nonprofit community health system based in San Diego, Calif. with 12,300 employees, five acute-care hospital campuses, home health care services, and an ambulatory care network of clinics and physician offices.

ABOUT NAVIGENICS

Navigenics, Inc. is a privately held company based in Redwood Shores, Calif. The company was founded by David Agus, M.D. and Dietrich Stephan, Ph.D., with the goa
'/>"/>